Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides

Ayman Hawrani1, Robin A Howe, Timothy R Walsh

  • 1Department of Cellular and Molecular Medicine, Bristol University, Bristol BS8 1TD, United Kingdom.

Insights

A novel antimicrobial peptide, RTA3, shows reduced toxicity to mammalian cells by not binding well to neutral membranes. This finding offers strategies for developing safer antimicrobial peptides.

Area of Science:

  • Biochemistry
  • Microbiology
  • Molecular Biology

Background:

  • A novel antimicrobial peptide, RTA3, from Streptococcus mitis exhibits potent activity against Gram-negative bacteria with low salt sensitivity and minimal toxicity.
  • RTA3 possesses a positively charged, amphipathic helical structure, but uniquely features a positively charged residue (Arg-5) on its nonpolar face upon membrane binding.

Purpose of the Study:

  • To investigate the role of the positively charged residue on the nonpolar face of RTA3 in minimizing mammalian cell toxicity.
  • To explore the binding interactions of RTA3 and its mutant with neutral and negatively charged membranes.

Main Methods:

  • Comparative analysis of RTA3 and an R5L mutant peptide with varying membrane compositions.
  • Spectroscopic techniques to analyze peptide conformation and membrane binding.
  • Determination of binding constants to neutral and negatively charged lipid bilayers.

Main Results:

  • The R5L mutant peptide exhibited significantly enhanced mammalian cell toxicity compared to wild-type RTA3.
  • Enhanced toxicity of the mutant correlated with increased binding and helical adoption upon interaction with neutral membranes.
  • Wild-type RTA3 demonstrated significantly reduced binding (over 1000-fold decrease) to neutral membranes, while accommodating negative charges without unfolding.
  • Tryptophan residues were identified as crucial for promoting amphipathic helical peptide binding to neutral bilayers.

Conclusions:

  • The presence of a positively charged residue on the nonpolar face of amphipathic helical peptides, like RTA3, is a key factor in reducing eukaryotic cell toxicity.
  • These peptides exhibit poor binding to neutral membranes, characteristic of eukaryotic cell membranes, thus contributing to their safety profile.
  • Understanding these binding specificities provides a strategic approach for designing safer and more effective antimicrobial peptides.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...